Nu Skin (NUS) Receives a Hold from D.A. Davidson
TipRanks (Fri, 10-May 9:05 AM ET)
Nu Skin Enterprises: Hold Rating with Cautious Outlook Amid Strategic Growth Initiatives
TipRanks (Thu, 9-May 6:09 AM ET)
Nu Skin declares $0.06 dividend
Seeking Alpha News (Thu, 9-May 4:54 AM ET)
Nu Skin Non-GAAP EPS of $0.09 beats by $0.04, revenue of $417.3M misses by $15.05M
Seeking Alpha News (Wed, 8-May 4:37 PM ET)
Nu Skin Enterprises Reports First Quarter Results
Business Wire (Wed, 8-May 4:06 PM ET)
Nu Skin Enterprises Announces Quarterly Dividend
Business Wire (Wed, 8-May 4:05 PM ET)
Notable earnings after Wednesday's close
Seeking Alpha News (Tue, 7-May 5:35 PM ET)
Nu Skin Enterprises to Announce First Quarter 2024 Financial Results
Business Wire (Wed, 3-Apr 4:05 PM ET)
Nu Skin Launches RenuSpa iO, a New Personalized Beauty and Wellness Device
PRNewswire (Tue, 27-Feb 7:00 AM ET)
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2023 Results Above Company Guidance
Business Wire (Wed, 14-Feb 4:05 PM ET)
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Nu Skin Enterprises trades on the NYSE stock market under the symbol NUS.
As of May 10, 2024, NUS stock price climbed to $13.22 with 834,328 million shares trading.
NUS has a beta of 0.48, meaning it tends to be less sensitive to market movements. NUS has a correlation of 0.02 to the broad based SPY ETF.
NUS has a market cap of $656.56 million. This is considered a Small Cap stock.
Last quarter Nu Skin Enterprises reported $417 million in Revenue and $.09 earnings per share. This fell short of revenue expectation by $-9 million and exceeded earnings estimates by $.04.
In the last 3 years, NUS stock traded as high as $62.70 and as low as $11.73.
The top ETF exchange traded funds that NUS belongs to (by Net Assets): IJR, VTI, VB, IWM, VBR.
NUS has underperformed the market in the last year with a return of -61.6%, while the SPY ETF gained +28.4%. In the last 3 month period, NUS fell short of the market, returning -24.5%, while SPY returned +4.2%. However, in the most recent 2 weeks NUS has outperformed the stock market by returning +8.0%, while SPY returned +3.4%.
NUS support price is $12.46 and resistance is $13.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUS stock will trade within this expected range on the day.